Loading...
Comparison of Single-Agent Androgen Suppression for Advanced Prostate Cancer
Gonadotropin-releasing hormone (GnRH) agonists are the agents of choice for achieving androgen suppression in men with advanced prostate cancer. The GnRH agonists that have been developed and marketed for prostate cancer are leuprolide, goserelin, triptorelin, and histrelin. So far, there have been...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MedReviews, LLC
2005
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1477619/ https://ncbi.nlm.nih.gov/pubmed/16985882 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|